Cargando…

Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis

BACKGROUND: Innovative GLP-1 receptor agonist (GLP-1RA)-based treatment strategies—such as tirzepatide, GLP-1RA plus basal insulin fixed-ratio combinations [FRC], GLP-1RA plus sodium glucose cotransporter-2 inhibitors [SGLT-2i] combinations, and high-dose GLP-1RA—have been listed among the most effi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caruso, Irene, Di Gioia, Ludovico, Di Molfetta, Sergio, Cignarelli, Angelo, Palmer, Suetonia Cressida, Natale, Patrizia, Strippoli, Giovanni F.M., Perrini, Sebastio, Natalicchio, Annalisa, Laviola, Luigi, Giorgino, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500557/ https://www.ncbi.nlm.nih.gov/pubmed/37719418 http://dx.doi.org/10.1016/j.eclinm.2023.102181

Ejemplares similares

Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies
por: Caruso, Irene, et al.
Publicado: (2022)

Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis
por: Castellana, Marco, et al.
Publicado: (2019)

Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
por: Castellana, Marco, et al.
Publicado: (2020)

Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis
por: Cignarelli, Angelo, et al.
Publicado: (2022)

Insulin and Insulin Receptors in Adipose Tissue Development
por: Cignarelli, Angelo, et al.
Publicado: (2019)

Diabetes in the Time of COVID-19: A Twitter-Based Sentiment Analysis
por: Cignarelli, Angelo, et al.
Publicado: (2020)

Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity
por: Marrano, Nicola, et al.
Publicado: (2021)

Role of Glucose-Lowering Medications in Erectile Dysfunction
por: Cignarelli, Angelo, et al.
Publicado: (2021)

The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor
por: D'Oria, Rossella, et al.
Publicado: (2020)

Cross-Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity
por: Leonardini, Anna, et al.
Publicado: (2009)

Effects of Extra Virgin Olive Oil Polyphenols on Beta-Cell Function and Survival
por: Marrano, Nicola, et al.
Publicado: (2021)

Effects of CPAP on Testosterone Levels in Patients With Obstructive Sleep Apnea: A Meta-Analysis Study
por: Cignarelli, Angelo, et al.
Publicado: (2019)

Impaired Leptin Signalling in Obesity: Is Leptin a New Thermolipokine?
por: Genchi, Valentina Annamaria, et al.
Publicado: (2021)

A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial
por: Di Molfetta, S., et al.
Publicado: (2022)

Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity
por: Marrano, Nicola, et al.
Publicado: (2023)

Differences in Gene Expression and Cytokine Release Profiles Highlight the Heterogeneity of Distinct Subsets of Adipose Tissue-Derived Stem Cells in the Subcutaneous and Visceral Adipose Tissue in Humans
por: Perrini, Sebastio, et al.
Publicado: (2013)

Implicazioni cliniche extraglicemiche dell’insulino-resistenza
por: Caporusso, Mariangela, et al.
Publicado: (2022)

TNFα Signals via p66(Shc) to Induce E-Selectin, Promote Leukocyte Transmigration and Enhance Permeability in Human Endothelial Cells
por: Laviola, Luigi, et al.
Publicado: (2013)

Hepatokines, bile acids and ketone bodies are novel Hormones regulating energy homeostasis
por: Garruti, Gabriella, et al.
Publicado: (2023)

Postprandial glucose and HbA1c are associated with severity of obstructive sleep apnoea in non-diabetic obese subjects
por: Cignarelli, A., et al.
Publicado: (2021)

Pharmacological modulation of adaptive thermogenesis: new clues for obesity management?
por: Genchi, V. A., et al.
Publicado: (2023)

Trace elements in glucometabolic disorders: an update
por: Wiernsperger, Nicolas, et al.
Publicado: (2010)

Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect
por: Tian, Huining, et al.
Publicado: (2020)

Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action
por: Tirabassi, Giacomo, et al.
Publicado: (2015)

Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study
por: Baviera, Marta, et al.
Publicado: (2022)

GLP-1 Receptor Agonists and Kidney Protection
por: Greco, Eulalia Valentina, et al.
Publicado: (2019)

Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations
por: Meier, Juris J., et al.
Publicado: (2021)

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
por: Xia, Haoming, et al.
Publicado: (2022)

One-Hour Post-Load Plasma Glucose and Altered Glucometabolic Profile in Youths with Overweight or Obesity
por: Di Bonito, Procolo, et al.
Publicado: (2023)

Impact of Dysfunctional Adipose Tissue Depots on the Cardiovascular System
por: D’Oria, Rossella, et al.
Publicado: (2022)

Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies
por: Fadini, Gian Paolo, et al.
Publicado: (2021)

Nondiabetic Glucometabolic Status and Progression of Aortic Stiffness: The Whitehall II Study
por: McEniery, Carmel M., et al.
Publicado: (2017)

Association of Nondiabetic Glucometabolic Status and Aortic Stiffness in Community Hypertension Patients
por: Zhou, Dan, et al.
Publicado: (2022)

Association of Nondiabetic Glucometabolic Status and Aortic Stiffness in Community Hypertension Patients [Letter]
por: Sayed Jaffar AlSharaf, Maryam, et al.
Publicado: (2022)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet)
por: Casula, Manuela, et al.
Publicado: (2022)

Glucometabolic changes influence hospitalization and outcome in patients with COVID-19: An observational cohort study
por: Clausen, Clara L., et al.
Publicado: (2022)

A multi-center study on glucometabolic response to bariatric surgery for different subtypes of obesity
por: Liu, Yao, et al.
Publicado: (2022)

The Cardiovascular Effects of GLP-1 Receptor Agonists
por: Okerson, Theodore, et al.
Publicado: (2012)

Clinical Trial Highlights – GLP-1 agonists
por: McFarthing, Kevin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t75naem7l068hlcnb6jm87aj5r